Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction

Ariana García Ojalvo, Jorge Berlanga Acosta, Yssel Mendoza Marí, Maday Fernández Mayola, Calixto Valdés Pérez, William Savigne Gutiérrez, Ileydis Iglesias Marichal, Eduardo Álvarez Seijas, Alicia Molina Kautzman, Angélica Estrada Pacheco, David G Armstrong

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The diabetic foot ulcer (DFU) is the leading cause of lower extremity amputation worldwide and is directly associated with comorbidity, disability and mortality. Oxidative stress mechanisms have been implicated in the pathogenesis of these wounds. Intra-lesional infiltration of epidermal growth factor has emerged as a potential therapeutic alternative to allow for physiological benefit while avoiding the proteolytic environment at the centre of the wound. The aim of this study was to characterise the response of patients with DFUs to epidermal growth factor treatment in terms of redox status markers. Experimental groups included patients with DFUs before and 3-4 weeks after starting treatment with epidermal growth factor; compensated and non-compensated diabetic patients without ulcers; and age-matched non-diabetic subjects. Evaluations comprised serum levels of oxidative stress and antioxidant reserve markers. Patients with DFUs exhibited the most disheveled biochemical profile, with elevated oxidative stress and low antioxidant reserves, with respect to non-ulcerated diabetic patients and to non-diabetic subjects. Epidermal growth factor intra-lesional administration was associated with a significant recovery of oxidative stress and antioxidant reserve markers. Altogether, our results indicate that epidermal growth factor intra-ulcer therapy contributes to restore systemic redox balance in patients with DFUs.

Original languageEnglish (US)
JournalInternational Wound Journal
DOIs
StateAccepted/In press - 2016

Fingerprint

Epidermal Growth Factor
Oxidative Stress
Wounds and Injuries
Antioxidants
Ulcer
Oxidation-Reduction
Diabetic Foot
Therapeutics
Amputation
Comorbidity
Lower Extremity
Mortality
Serum

Keywords

  • Diabetes
  • Diabetes complications
  • Diabetic foot ulcers
  • Epidermal growth factor
  • Oxidative stress

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction. / Ojalvo, Ariana García; Acosta, Jorge Berlanga; Marí, Yssel Mendoza; Mayola, Maday Fernández; Pérez, Calixto Valdés; Gutiérrez, William Savigne; Marichal, Ileydis Iglesias; Seijas, Eduardo Álvarez; Kautzman, Alicia Molina; Pacheco, Angélica Estrada; Armstrong, David G.

In: International Wound Journal, 2016.

Research output: Contribution to journalArticle

Ojalvo, Ariana García ; Acosta, Jorge Berlanga ; Marí, Yssel Mendoza ; Mayola, Maday Fernández ; Pérez, Calixto Valdés ; Gutiérrez, William Savigne ; Marichal, Ileydis Iglesias ; Seijas, Eduardo Álvarez ; Kautzman, Alicia Molina ; Pacheco, Angélica Estrada ; Armstrong, David G. / Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction. In: International Wound Journal. 2016.
@article{d90ad75befcc402b9335d776b7a87b43,
title = "Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction",
abstract = "The diabetic foot ulcer (DFU) is the leading cause of lower extremity amputation worldwide and is directly associated with comorbidity, disability and mortality. Oxidative stress mechanisms have been implicated in the pathogenesis of these wounds. Intra-lesional infiltration of epidermal growth factor has emerged as a potential therapeutic alternative to allow for physiological benefit while avoiding the proteolytic environment at the centre of the wound. The aim of this study was to characterise the response of patients with DFUs to epidermal growth factor treatment in terms of redox status markers. Experimental groups included patients with DFUs before and 3-4 weeks after starting treatment with epidermal growth factor; compensated and non-compensated diabetic patients without ulcers; and age-matched non-diabetic subjects. Evaluations comprised serum levels of oxidative stress and antioxidant reserve markers. Patients with DFUs exhibited the most disheveled biochemical profile, with elevated oxidative stress and low antioxidant reserves, with respect to non-ulcerated diabetic patients and to non-diabetic subjects. Epidermal growth factor intra-lesional administration was associated with a significant recovery of oxidative stress and antioxidant reserve markers. Altogether, our results indicate that epidermal growth factor intra-ulcer therapy contributes to restore systemic redox balance in patients with DFUs.",
keywords = "Diabetes, Diabetes complications, Diabetic foot ulcers, Epidermal growth factor, Oxidative stress",
author = "Ojalvo, {Ariana Garc{\'i}a} and Acosta, {Jorge Berlanga} and Mar{\'i}, {Yssel Mendoza} and Mayola, {Maday Fern{\'a}ndez} and P{\'e}rez, {Calixto Vald{\'e}s} and Guti{\'e}rrez, {William Savigne} and Marichal, {Ileydis Iglesias} and Seijas, {Eduardo {\'A}lvarez} and Kautzman, {Alicia Molina} and Pacheco, {Ang{\'e}lica Estrada} and Armstrong, {David G}",
year = "2016",
doi = "10.1111/iwj.12592",
language = "English (US)",
journal = "International Wound Journal",
issn = "1742-4801",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction

AU - Ojalvo, Ariana García

AU - Acosta, Jorge Berlanga

AU - Marí, Yssel Mendoza

AU - Mayola, Maday Fernández

AU - Pérez, Calixto Valdés

AU - Gutiérrez, William Savigne

AU - Marichal, Ileydis Iglesias

AU - Seijas, Eduardo Álvarez

AU - Kautzman, Alicia Molina

AU - Pacheco, Angélica Estrada

AU - Armstrong, David G

PY - 2016

Y1 - 2016

N2 - The diabetic foot ulcer (DFU) is the leading cause of lower extremity amputation worldwide and is directly associated with comorbidity, disability and mortality. Oxidative stress mechanisms have been implicated in the pathogenesis of these wounds. Intra-lesional infiltration of epidermal growth factor has emerged as a potential therapeutic alternative to allow for physiological benefit while avoiding the proteolytic environment at the centre of the wound. The aim of this study was to characterise the response of patients with DFUs to epidermal growth factor treatment in terms of redox status markers. Experimental groups included patients with DFUs before and 3-4 weeks after starting treatment with epidermal growth factor; compensated and non-compensated diabetic patients without ulcers; and age-matched non-diabetic subjects. Evaluations comprised serum levels of oxidative stress and antioxidant reserve markers. Patients with DFUs exhibited the most disheveled biochemical profile, with elevated oxidative stress and low antioxidant reserves, with respect to non-ulcerated diabetic patients and to non-diabetic subjects. Epidermal growth factor intra-lesional administration was associated with a significant recovery of oxidative stress and antioxidant reserve markers. Altogether, our results indicate that epidermal growth factor intra-ulcer therapy contributes to restore systemic redox balance in patients with DFUs.

AB - The diabetic foot ulcer (DFU) is the leading cause of lower extremity amputation worldwide and is directly associated with comorbidity, disability and mortality. Oxidative stress mechanisms have been implicated in the pathogenesis of these wounds. Intra-lesional infiltration of epidermal growth factor has emerged as a potential therapeutic alternative to allow for physiological benefit while avoiding the proteolytic environment at the centre of the wound. The aim of this study was to characterise the response of patients with DFUs to epidermal growth factor treatment in terms of redox status markers. Experimental groups included patients with DFUs before and 3-4 weeks after starting treatment with epidermal growth factor; compensated and non-compensated diabetic patients without ulcers; and age-matched non-diabetic subjects. Evaluations comprised serum levels of oxidative stress and antioxidant reserve markers. Patients with DFUs exhibited the most disheveled biochemical profile, with elevated oxidative stress and low antioxidant reserves, with respect to non-ulcerated diabetic patients and to non-diabetic subjects. Epidermal growth factor intra-lesional administration was associated with a significant recovery of oxidative stress and antioxidant reserve markers. Altogether, our results indicate that epidermal growth factor intra-ulcer therapy contributes to restore systemic redox balance in patients with DFUs.

KW - Diabetes

KW - Diabetes complications

KW - Diabetic foot ulcers

KW - Epidermal growth factor

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84961801339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961801339&partnerID=8YFLogxK

U2 - 10.1111/iwj.12592

DO - 10.1111/iwj.12592

M3 - Article

JO - International Wound Journal

JF - International Wound Journal

SN - 1742-4801

ER -